BOCA RATON, FL--(Marketwired - Oct 31, 2013) - Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO), a medical device company with a suite of FDA cleared products, announced today it has been granted ...
BOCA RATON, FL--(Marketwired - May 3, 2013) - Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) announced today that it is adding to the expertise on its board of directors with the appointment of Lowell ...
BOCA RATON, FL--(Marketwired - Aug 5, 2014) - Vycor Medical, Inc. ("Vycor" or the "Company") (OTCQB: VYCO), today announces that its largest shareholder, Fountainhead Capital Management Limited ...
Vycor Medical develops devices for neurosurgery and vision rehabilitation. Its main product, the ViewSite Brain Access System (VBAS), is a neurosurgical device designed to enable safer access to areas ...
BOCA RATON, FL, March 27, 2020 (GLOBE NEWSWIRE) -- Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for ...
Vycor Medical, Inc. ("Vycor") (OTCBB: VYCO) announced today that it has finalized the production and the U.S. commercial launch of an extension arm for its existing ViewSite™ Brain Access System ...
BOCA RATON, FL--(Marketwired - May 29, 2014) - Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, today announced that David Cantor, ...
B2i Digital to Showcase Vycor Medical's Neurosurgical and Vision Rehabilitation Technologies NEW YORK, NY - March 13, 2025 (NEWMEDIAWIRE) - B2i Digital is pleased to announce that Vycor Medical, Inc. ...
Vycor Medical, Inc. (OTCBB: VYCO) (www.vycormedical.com), a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced the appointment ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Vycor Medical operates through two distinct business units, each focused on addressing critical needs in neurosurgery and vision rehabilitation. Vycor Medical is addressing two significant areas of ...
Revenue climbed 22% (GAAP) for the three months ended June 30, 2025, compared to the prior year period, largely due to international growth in the Vycor Medical division. Non-GAAP operating profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results